FHLC vs IBB: holdings overlap, shared companies and scores
As of September 11, 2026, FHLC and IBB overlap 18.7% by weight. Fidelity MSCI Health Care Index ETF (FHLC): U.S. healthcare companies iShares Biotechnology ETF (IBB): U.S. biotechnology stocks.
Updated September 11, 2026
How much do FHLC and IBB overlap?
As of September 11, 2026, FHLC and IBB overlap 18.7% by weight.
19% of FHLC is already inside IBB.
87% of IBB is already inside FHLC.
FHLC holds 331 companies and IBB holds 239; 139 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score FHLC and IBB?
As of September 11, 2026, ETF Copilot scores FHLC 5.5 out of 10 and IBB 3.1 out of 10.
They differ most on Growth: FHLC 7.7 and IBB 1.9.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | FHLC | IBB |
|---|---|---|
| Growth | 7.7 | 1.9 |
| Valuation | 3.8 | 3.5 |
| Risk | 8.3 | 4.2 |
| Quality | 3.9 | 3.4 |
| Return | 3.5 | 3.1 |
FHLC is the cheaper of the two at 0.08% a year
As of September 11, 2026, FHLC charges 0.08% a year, yields 1.55% and holds $3.5B in assets across 331 positions.
As of September 11, 2026, IBB charges 0.44% a year, yields 0.46% and holds $10.7B in assets across 239 positions.
| Measure | FHLC | IBB |
|---|---|---|
| Expense ratio | 0.08% | 0.44% |
| Dividend yield | 1.55% | 0.46% |
| Assets under management | $3.5B | $10.7B |
| Holdings | 331 | 239 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Where FHLC and IBB trade against their own history
FHLC trades at 30.0 times earnings, against its own median of 24.8, and is more expensive than 89% of its own 114 monthly readings since 2017.
IBB trades at 22.7 times earnings, against its own median of 21.5, and is more expensive than 60% of its own 114 monthly readings since 2017.
What moved FHLC and IBB this week
FHLC fell 4.4% in the week to September 11, 2026. The holdings that moved it most were Eli Lilly (−3.8%), Amgen (−15.0%) and Johnson & Johnson (−4.6%); Roivant Sciences (+18.6%) pushed the other way.
IBB fell 5.1% in the week to September 11, 2026. The holdings that moved it most were Amgen (−15.0%), Vertex Pharmaceuticals (−7.6%) and Regeneron Pharmaceuticals (−7.3%); Roivant Sciences (+18.6%) pushed the other way.
What do FHLC and IBB each hold?
What's inside FHLC: AI 0%, Tech 0%.
52% of FHLC is its ten largest holdings.
What's inside IBB: AI 1%.
48% of IBB is its ten largest holdings.
Compare with similar funds
Cite this
ETF Copilot, “FHLC vs IBB holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/fhlc-vs-ibb
Register free to unlock FHLC vs IBB prices and holdings on ETF Copilot.
Register free →